Yasheng Group

Print
Claim My Business
Location
SAN JOSE, CA
Expected Close Date
August 21, 2023
Target Raise
$10.00K-$5.00M
Security Price
$0.25
Number of Employees
245
Cash
$4,176,049
Revenue
$18,588,589
Short Term Debt
$0
Cost of Goods
$13,001,365
Long Term Debt
$0
Net Income
$5,307,372

Company Description

Yasheng Group is a U.S. company, that conducts business operations in the US, China, and the Philippines in four major segments: Agriculture & Fisheries, Biotechnology, Blockchain, and Mining. Yasheng Group plans to raise this round for the Biotechnology segment of their company, and more specifically, for Jove Therapeutics. Jove Therapeutic’s mission is to expand tomorrow’s cutting-edge technology for the development of multiple myeloma and other cancer treatment.

Management Team / Advisory Board Bios

Anxue Wang

Director

BackgroundAnxue Wang served as a Senior Engineer with the Suzhou Municipal Water Affairs Bureau in China from2000 to 2010, in charge of water resources engineering survey and design. During that period, he won a Second Prize in Science and Technology Progress at the Gansu Province level. Mr. Wang currently is an independent director. He also serves as both a member of the Compensation Committee and a member of the Audit Committee.
Amount Raised : $3,250
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments